MUSCAT: Oman has agreed to fast-track the approval of Indian pharma products registered by regulatory agencies in the US, the UK and the EU, the commerce and industry ministry said after the 10th India-Oman Joint Commission Meeting on Wednesday.
“Fast-tracking of approvals for registration of Indian pharmaceutical products already registered by US Food and Drug Administration (US FDA), UK’s Medicines and Healthcare products Regulatory Agency (UKMHRA) and European Medicines Agency (EMA) was agreed to during the deliberations,” a statement released by the ministry said.
“Both sides expressed commitment to facilitate trade and to comprehensively address all issues pertaining to Tariff ot Non-Tariff Barriers.
“Agreement on expeditious conclusion of all Memorandum of Understanding (MoUs) or Agreements under discussion, including on standards and metrology, India-Oman Double Taxation Avoidance Agreement, India-Oman Bilateral Investment Treaty, Invest Oman and Invest India, and Rupay card acceptance in Oman,” the ministry added.
Read More
- Uzbek president concludes Oman state visit after signing strategic partnership pact
- Muscat Municipality announces National Day events at Al Khuwair Square
- Oman, Uzbekistan pursue preferential trade deal as they target $500 million in bilateral trade
- His Majesty Sultan Haitham, Uzbek president discuss closer ties in Muscat
- Oman, Iran foreign ministers discuss maritime security in Muscat
His Excellency Qais Al Yousef, Minister of Commerce, Industry and Investment Promotion is currently visiting India as part of the 10th India-Oman Joint Committee Meet.





